We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Results 1 to 2 of 2

Implications for personalized medicine after Myriad

USA - June 20 2013 On June 13, 2013, in the highly anticipated decision for Ass'n for Molecular Pathology v. Myriad Genetics, Inc., the Supreme Court shed some light on…

Co-authors: Kenya S. Woodruff.

How much would you pay for this lovely expedited examination? USPTO approves priority utility and plant patent application examination

USA - April 5 2011 On April 4, 2011, the U.S. Patent and Trademark Office (USPTO) issued a Final Rule implementing the prioritized examination track (“Track I”) of its new examination timing control procedures.

Co-authors: Tom Chen, Jeffrey A. Wolfson.